|
[1]
|
Fredriksson, R., Lagerström, M.C., Lundin, L.G., et al. (2003) The G-Protein-Coupled Receptors in the Human Genome form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints. Molecular Pharmacology, 63, 1256-1272. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Karchin, R., Karplus, K. and Haussler, D. (2002) Classifying G-Protein Coupled Receptors with Support Vector Machines. Bioinformatics, 18, 147-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Brink, C.B., Harvey, B.H., Bodenstein, J., et al. (2004) Recent Advances in Drug Action and Therapeutics: Relevance of Novel Concepts in G-Protein-Coupled Receptor and Signal Transduction Pharmacology. British Journal of Clinical Pharmacology, 57, 373-387. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Gether U. (2000) Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors. Endocrine Reviews, 21, 90-113. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Neyman, A. and Eugster, E.A. (2017) Treatment of Girls and Boys with McCune-Albright Syndrome with Precocious Puberty—Update 2017. Pediatric Endocrinology Reviews, 15, 136-141.
|
|
[6]
|
Lumbroso, S., Paris, F. and Sultan, C. (2004) Activating Gsalpha Mutations: Analysis of 113 Patients with Signs of McCune-Albright Syndrome—A European Collaborative Study. The Journal of Clinical Endocrinology & Metabolism, 89, 2107-2113. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Hartley, I., Zhadina, M., Collins, M.T., et al. (2019) Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review. Calcified Tissue International, 104, 517-529. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Javaid, M.K., Boyce, A., Appelman-Dijkstra, N., et al. (2019) Best Practice Management Guidelines for Fibrous Dysplasia/McCune-Albright Syndrome: A Consensus Statement from the FD/MAS International Consortium. Orphanet Journal of Rare Diseases, 14, 139. [Google Scholar] [CrossRef] [PubMed]
|